-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
William Blair Initiates Coverage on Terns Pharmaceuticals (NASDAQ:TERN)
Equities researchers at William Blair started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) in a research note issued to investors on Friday, Marketbeat reports. The firm set a “market perform” rating on the stock. A number of other equities analysts have also recently issued reports on TERN. Oppenheimer upped their target […]
Equities researchers at William Blair started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) in a research note issued to investors on Friday, Marketbeat reports. The firm set a “market perform” rating on the stock. A number of other equities analysts have also recently issued reports on TERN. Oppenheimer upped their target […]
